Gene expression profiling, which interrogates multiple immune-related genes, is increasingly recognized as an attractive approach to characterizing the tumor immune microenvironment and predicting the response to immunotherapy, since it goes further than the measurement of single genes such as PD-L1. The gene discussed is CD274; the disease is neoplasm.